StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Research analysts at StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a report issued on Tuesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

Shares of NASDAQ:CUTR opened at $0.04 on Tuesday. The stock has a 50 day moving average of $0.37 and a 200 day moving average of $0.49. The company has a market cap of $787,254.00, a PE ratio of -0.01 and a beta of 1.36. Cutera has a 12-month low of $0.09 and a 12-month high of $3.00.

Institutional Trading of Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP acquired a new position in Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera as of its most recent SEC filing. 90.70% of the stock is currently owned by institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.